Document is current
Any future updates will be listed below
-
Authors
Anczukow, Olga https://orcid.org/0000-0003-0516-2677
Allain, Frédéric H.-T.
Angarola, Brittany L.
Black, Douglas L. https://orcid.org/0000-0002-2705-8187
Brooks, Angela N. https://orcid.org/0000-0002-7898-3073
Cheng, Chonghui
Conesa, Ana
Crosse, Edie I.
Eyras, Eduardo https://orcid.org/0000-0003-0793-6218
Guccione, Ernesto https://orcid.org/0000-0001-7764-5307
Lu, Sydney X.
Neugebauer, Karla M. https://orcid.org/0000-0002-3835-6761
Sehgal, Priyanka
Song, Xiao
Tothova, Zuzana https://orcid.org/0000-0001-6668-532X
Valcárcel, Juan https://orcid.org/0000-0001-5398-3571
Weeks, Kevin M. https://orcid.org/0000-0002-6748-9985
Yeo, Gene W. https://orcid.org/0000-0002-0799-6037
Thomas-Tikhonenko, Andrei https://orcid.org/0000-0002-2739-2206
- License Information
-
More Information
Article History
Accepted: 27 August 2024
First Online: 9 October 2024
Competing interests
: J.V. is a member of the Advisory Boards of Remix Therapeutics, Stoke Therapeutics and IntronX. K.M.W. is an adviser to and holds equity in Ribometrix, ForagR Medicines and A-Form Solutions. O.A. is a member of the Advisory Boards of Caeruleus Genomics.
